Literature DB >> 14709160

Identification of a Ser/Thr cluster in the C-terminal domain of the human prostaglandin receptor EP4 that is essential for agonist-induced beta-arrestin1 recruitment but differs from the apparent principal phosphorylation site.

Frank Neuschäfer-Rube1, Ricardo Hermosilla, Mathias Rehwald, Lars Rönnstrand, Ralf Schülein, Christer Wernstedt, Gerhard Paul Püschel.   

Abstract

hEP4-R (human prostaglandin E2 receptor, subtype EP4) is a G(s)-linked heterotrimeric GPCR (G-protein-coupled receptor). It undergoes agonist-induced desensitization and internalization that depend on the presence of its C-terminal domain. Desensitization and internalization of GPCRs are often linked to agonist-induced beta-arrestin complex formation, which is stabilized by phosphorylation. Subsequently beta-arrestin uncouples the receptor from its G-protein and links it to the endocytotic machinery. The C-terminal domain of hEP4-R contains 38 Ser/Thr residues that represent potential phosphorylation sites. The present study aimed to analyse the relevance of these Ser/Thr residues for agonist-induced phosphorylation, interaction with beta-arrestin and internalization. In response to agonist treatment, hEP4-R was phosphorylated. By analysis of proteolytic phosphopeptides of the wild-type receptor and mutants in which groups of Ser/Thr residues had been replaced by Ala, the principal phosphorylation site was mapped to a Ser/Thr-containing region comprising residues 370-382, the presence of which was necessary and sufficient to obtain full agonist-induced phosphorylation. A cluster of Ser/Thr residues (Ser-389-Ser-390-Thr-391-Ser-392) distal to this site, but not the principal phosphorylation site, was essential to allow agonist-induced recruitment of beta-arrestin1. However, phosphorylation greatly enhanced the stability of the beta-arrestin1-receptor complexes. For maximal agonist-induced internalization, phosphorylation of the principal phosphorylation site was not required, but both beta-arrestin1 recruitment and the presence of Ser/Thr residues in the distal half of the C-terminal domain were necessary.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14709160      PMCID: PMC1224101          DOI: 10.1042/BJ20031820

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Desensitization of the isolated beta 2-adrenergic receptor by beta-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms.

Authors:  J Pitcher; M J Lohse; J Codina; M G Caron; R J Lefkowitz
Journal:  Biochemistry       Date:  1992-03-31       Impact factor: 3.162

2.  The long cytoplasmic carboxyl terminus of the prostaglandin E2 receptor EP4 subtype is essential for agonist-induced desensitization.

Authors:  M Bastepe; B Ashby
Journal:  Mol Pharmacol       Date:  1997-02       Impact factor: 4.436

Review 3.  Molecular mechanisms of membrane receptor desensitization.

Authors:  M J Lohse
Journal:  Biochim Biophys Acta       Date:  1993-11-07

4.  Two Gs-coupled prostaglandin E receptor subtypes, EP2 and EP4, differ in desensitization and sensitivity to the metabolic inactivation of the agonist.

Authors:  N Nishigaki; M Negishi; A Ichikawa
Journal:  Mol Pharmacol       Date:  1996-10       Impact factor: 4.436

5.  Desensitization and internalization of the m2 muscarinic acetylcholine receptor are directed by independent mechanisms.

Authors:  R Pals-Rylaarsdam; Y Xu; P Witt-Enderby; J L Benovic; M M Hosey
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

Review 6.  International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.

Authors:  R A Coleman; W L Smith; S Narumiya
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

7.  Rhodopsin phosphorylation sites and their role in arrestin binding.

Authors:  L Zhang; C D Sports; S Osawa; E R Weiss
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

8.  Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor.

Authors:  O B Goodman; J G Krupnick; F Santini; V V Gurevich; R B Penn; A W Gagnon; J H Keen; J L Benovic
Journal:  Nature       Date:  1996-10-03       Impact factor: 49.962

9.  Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, beta 2-adrenergic, and m2 muscarinic cholinergic receptors.

Authors:  V V Gurevich; S B Dion; J J Onorato; J Ptasienski; C M Kim; R Sterne-Marr; M M Hosey; J L Benovic
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

Review 10.  Protein kinases that phosphorylate activated G protein-coupled receptors.

Authors:  R T Premont; J Inglese; R J Lefkowitz
Journal:  FASEB J       Date:  1995-02       Impact factor: 5.191

View more
  16 in total

1.  Role of beta-arrestin 1 in the metastatic progression of colorectal cancer.

Authors:  F Gregory Buchanan; D Lee Gorden; Pranathi Matta; Qiong Shi; Lynn M Matrisian; Raymond N DuBois
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 2.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

3.  NF-κB-dependent IL-8 induction by prostaglandin E(2) receptors EP(1) and EP(4).

Authors:  F Neuschäfer-Rube; A Pathe-Neuschäfer-Rube; S Hippenstiel; M Kracht; G P Püschel
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

4.  PGE2 /EP4 receptor attenuated mucosal injury via β-arrestin1/Src/EGFR-mediated proliferation in portal hypertensive gastropathy.

Authors:  Siwei Tan; Xiaoliang Chen; Minyi Xu; Xiaoli Huang; Huiling Liu; Jie Jiang; Yu Lu; Xiaojie Peng; Bin Wu
Journal:  Br J Pharmacol       Date:  2017-03-25       Impact factor: 8.739

Review 5.  A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2020-09-24       Impact factor: 5.782

6.  Role of the ERC motif in the proximal part of the second intracellular loop and the C-terminal domain of the human prostaglandin F2alpha receptor (hFP-R) in G-protein coupling control.

Authors:  Andrea Pathe-Neuschäfer-Rube; Frank Neuschäfer-Rube; Gerhard P Püschel
Journal:  Biochem J       Date:  2005-05-15       Impact factor: 3.857

7.  A Ser/Thr cluster within the C-terminal domain of the rat prostaglandin receptor EP3alpha is essential for agonist-induced phosphorylation, desensitization and internalization.

Authors:  Frank Neuschäfer-Rube; Ricardo Hermosilla; Manuela Kuna; Andrea Pathe-Neuschäfer-Rube; Ralf Schülein; Gerhard Paul Püschel
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

Review 8.  β-Arrestin-mediated receptor trafficking and signal transduction.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  Trends Pharmacol Sci       Date:  2011-06-15       Impact factor: 14.819

Review 9.  The Prostaglandin Transporter: Eicosanoid Reuptake, Control of Signaling, and Development of High-Affinity Inhibitors as Drug Candidates.

Authors:  Victor L Schuster; Yuling Chi; Run Lu
Journal:  Trans Am Clin Climatol Assoc       Date:  2015

Review 10.  β-Arrestins in the immune system.

Authors:  Dianhua Jiang; Ting Xie; Jiurong Liang; Paul W Noble
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.